|
Microbot Medical Inc. (MBOT) DCF -Bewertung
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Microbot Medical Inc. (MBOT) Bundle
Erforschen Sie die finanziellen Aussichten von Microbot Medical Inc. (MBOT) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Annahmen in Bezug auf Wachstum, Margen und Kosten ein, um den inneren Wert von Microbot Medical Inc. (MBOT) zu berechnen und Ihre Anlageentscheidungen zu formen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -7.2 | -9.0 | -11.3 | -13.2 | -10.6 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .1 | .1 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -7.2 | -9.1 | -11.4 | -13.3 | -10.7 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 31.3 | 24.6 | 15.5 | 8.2 | 6.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | .3 | .2 | .0 | 1.3 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | -2.6 | .0 | -.2 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .3 | .3 | .3 | .1 | .4 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.2 | -.1 | -.1 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -7.3 | -9.2 | -11.3 | 105.7 | -10.7 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4.7 | -12.1 | -11.0 | 105.7 | -11.8 | .9 | .0 | .0 | .0 | .0 |
| WACC, % | 11.06 | 11.06 | 11.06 | 10.99 | 11.06 | 11.05 | 11.05 | 11.05 | 11.05 | 11.05 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 1 | |||||||||
| Net Debt | -2 | |||||||||
| Equity Value | 3 | |||||||||
| Diluted Shares Outstanding, MM | 10 | |||||||||
| Equity Value Per Share | 0.30 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios.
- Real-World Data: Microbot Medical Inc. (MBOT) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and saving time.
Key Features
- Comprehensive Data Access: Microbot Medical Inc.’s (MBOT) detailed historical financials and projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Watch Microbot Medical Inc.’s (MBOT) intrinsic value update instantly.
- Intuitive Visualizations: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- 1. Access the Template: Download and open the Excel file containing Microbot Medical Inc.'s (MBOT) preloaded data.
- 2. Adjust Key Inputs: Modify essential parameters such as growth rates, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV in real-time.
- 4. Explore Different Scenarios: Evaluate various forecasts to assess multiple valuation possibilities.
- 5. Present with Assurance: Deliver expert valuation insights to back your strategic decisions.
Why Choose This Calculator for Microbot Medical Inc. (MBOT)?
- Precision: Utilizes real Microbot Medical financials for utmost data reliability.
- Adaptability: Built to allow users to experiment and adjust inputs with ease.
- Efficiency: Eliminate the need to construct a DCF model from the ground up.
- Expert-Level: Crafted with the accuracy and functionality expected by CFOs.
- Intuitive: Simple to navigate, even for those lacking advanced financial modeling skills.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for portfolio assessment related to Microbot Medical Inc. (MBOT).
- Medical Device Companies: Evaluate valuation scenarios to inform strategic decisions within the industry.
- Consultants and Advisors: Offer clients precise valuation insights for Microbot Medical Inc. (MBOT) stock.
- Students and Educators: Leverage real-world data to practice and teach financial modeling in the healthcare sector.
- Tech and Medical Enthusiasts: Gain insights into how innovative companies like Microbot Medical Inc. (MBOT) are valued in the market.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring in-depth valuation calculations.
- Real-World Data: Microbot Medical Inc.'s (MBOT) historical and projected financials preloaded for analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Visualizations and tables for clear, actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.